The American College of Cardiology (ACC) has announced five Late-Breaking Clinical Trial Sessions, two Late-Breaking Clinical Trial Deep Dive Sessions, and three Featured Clinical Research sessions to be presented during its annual scientific session, “ACC with WCC,” or ACC.23/WCC to be held March 4-6 in New Orleans, LA.
Feature | ACC | Christine Book
Late-breaking Clinical Trials, Featured Clinical Research Sessions Announced for American College of Cardiology ACC.23/WCC

February 16, 2023 — The American College of Cardiology (ACC) has announced five Late-Breaking Clinical Trial Sessions ...

Home February 16, 2023
Home
Noise-induced stress causes the release of stress hormones that trigger an inflammatory response, leading to more severe myocardial infarction, oxidative stress and endothelial dysfunction, and subsequent heart failure.
News | Cardiovascular Clinical Studies
Aircraft Noise Increases Damage from Myocardial Infarction

February 16, 2023 — Traffic noise may play an essential role in the development and deterioration of ischemic heart ...

Home February 16, 2023
Home
Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters, announced this week it has received FDA 510(k) clearance for reprocessing the Philips IVUS Eagle Eye Platinum RX Digital catheter.
News | Intra-Vascular Ultrasound (IVUS)
Northeast Scientific Inc. awarded 510(k) clearance to reprocess the Eagle Eye Platinum RX Digital IVUS Catheter

February 16, 2023 — Northeast Scientific Inc., the pioneers in reprocessing single use peripheral vascular catheters ...

Home February 16, 2023
Home
Acute ischemic stroke patients with each PIRI score on 5-point scale
News | Stroke
Percent Insular Ribbon Infarction for Growth Rate Prediction, Outcomes in Large-Vessel Occlusive Stroke

February 16, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) ...

Home February 16, 2023
Home
The American College of Cardiology (ACC) will be joining with the World Heart Federation (WHF), in conjunction with the World Congress of Cardiology (WCC) for “ACC.23 Together with WCC,” to be held in New Orleans, LA, March 4 – 6, 2023. Program highlights for ACC.23/WCC are offered by the ITN team in this first of a multi-segment overview. Logo image courtesy of ACC.
Feature | ACC | Christine Book
American College of Cardiology Announces “ACC.23 Together with WCC” Program Highlights

February 15, 2023 — The American College of Cardiology (ACC) will be joining with the World Heart Federation (WHF), in ...

Home February 15, 2023
Home
Abbott and Cardiovascular Systems, Inc. (CSI), announced a definitive agreement for Abbott to acquire CSI, a medical device company with an innovative atherectomy system used in treating peripheral and coronary artery disease.
News | Atherectomy Devices
Abbott to Acquire Cardiovascular Systems, Inc.

February 15, 2023 — Abbott and Cardiovascular Systems, Inc. (CSI), announced a definitive agreement for Abbott to ...

Home February 15, 2023
Home
LACI-2 shows reduction in cognitive decline after lacunar stroke
News | Stroke
ISC23 Late-breaker: A New Strategy to Improve Stroke Thrombolysis

February 15, 2023 — Thrombolysis use increased from 4% in 2010 to 14% in 2020 in the traditionally underserved urban ...

Home February 15, 2023
Home
The secure nationwide AI-powered cloud platform streamlines care team communication and delivers patient-specific imaging insights within clinical workflows
News | Artificial Intelligence
Nanox.AI Connects to Nuance Precision Imaging Network to Improve Early Detection of Chronic Diseases with Workflow-integrated AI

February 15, 2023 — Nano-X Imaging Ltd, an innovative medical imaging technology company, announced that its deep ...

Home February 15, 2023
Home
VST-Bio's Collaborators Present Preclinical Trial Results at the American Heart Association International Stroke Conference in Dallas.
News | Stroke
VST-BIO Announces Successful Preclinical Trials in Ischemic Stroke

February 14, 2023 — VST-Bio Corp. a leader in the development of innovative biologics to treat acute and chronic ...

Home February 14, 2023
Home
Late breaking analysis of one-year outcomes from the inspIRE clinical study demonstrated early success at the prespecified interim analysis
News | Atrial Fibrillation
First Look at Data on Biosense Webster's Investigational Pulsed Field Ablation Platform Presented at AF Symposium 2023

February 14, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home February 14, 2023
Home
Led by University Hospitals stroke director Amrou Sarraj, MD, SELECT2 study results in New England Journal of Medicine presented at International Stroke Conference
News | Stroke
New Major International Study Finds Thrombectomy Highly Effective Treatment for Large Strokes

February 14, 2023 — A large international clinical study finds that patients with large strokes had a dramatically ...

Home February 14, 2023
Home
Radiology, the flagship journal of the Radiological Society of North America (RSNA), and the leading journal in the field of medical imaging, will feature special centennial content this year in connection with the publication’s 100th anniversary.
News | Artificial Intelligence
DiA Received FDA Clearance for New AI Software, Helping Ultrasound Users Capture High-Quality Images

February 14, 2023 —DiA Imaging Analysis, a leading provider of advanced AI-based software solutions for ultrasound image ...

Home February 14, 2023
Home
Lowering blood pressure after clot removal may not be safe, and should be individualized, according to findings of the BEST II Trial presented during the American Stroke Association International Stroke Conference. Photo credit: Getty Images
News | Stroke
BEST II Clinical Trial Findings Reported at International Stroke Conference: Proceed with Caution on Blood Pressure Meds after Clot Removal

February 14, 2023 — Using blood pressure medications to lower systolic blood pressure immediately after mechanical clot ...

Home February 14, 2023
Home
American Stroke Association International Stroke Conference – Late-Breaking Science Presentations LB4 and LB12
News | Stroke
Two Cardiovascular Medicines were Well-tolerated for Small Vessel Stroke

February 10, 2023 — A study of two widely used cardiovascular medications — cilostazol and isosorbide mononitrate — in ...

Home February 10, 2023
Home
The rate of death was four times lower among people who received the neuroprotectant medication, ApTOLL, compared to those receiving a placebo in a multi-nation study
News | Stroke
Medication that Protects Brain Tissue Linked to Improved Stroke Survival

February 10, 2023 — The neuroprotectant ApTOLL, a medication that may shield the brain from tissue damage, was linked to ...

Home February 10, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now